Throwing new light on lung cancer pathogenesis: Updates on three recent topics
Open Access
- 21 February 2005
- journal article
- review article
- Published by Wiley in Cancer Science
- Vol. 96 (2) , 63-68
- https://doi.org/10.1111/j.1349-7006.2005.00021.x
Abstract
Lung cancers have become the leading cause of cancer deaths in Japan, claiming more than 55 000 lives annually. Unfortunately, substantial improvement in terms of cure rates has not been achieved over the last two decades, although during the same period of time in‐depth basic knowledge of the molecular mechanisms, which underlies carcinogenesis and progression of this deadly group of neoplasms, has accumulated at an amazing pace. It has consequently become evident that they have many shared but also distinct features, when comparisons are made not only with other common epithelial cancers of adults, such as colon cancer, but also within the various histologic types of lung cancers themselves. This review article provides an up‐date on cutting‐edge research into the following three different topics, from which important new insights have been obtained. The first concerns genetic instability, especially chromosome instability, and checkpoint failure in lung cancers. Second, we deal with EGFR mutations, which shows revealing specificities in various aspects. Finally, advances in the expression profiling analysis of both transcriptomes and proteomes of lung cancers are summarized. (Cancer Sci 2005; 96: 63–68)This publication has 41 references indexed in Scilit:
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Decreased expression of 14-3-3σ in neuroendocrine tumors is independent of origin and malignant potentialOncogene, 2002
- Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancerOncogene, 2002
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancersOncogene, 2002
- Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancersOncogene, 1999
- Mutational Activation of the K-rasOncogeneNew England Journal of Medicine, 1987